September 2024 Br J Cardiol 2024;31:106–110 doi:10.5837/bjc.2024.037
Amanda Crundall, Mary Crawshaw-Ralli, Ahmet Fuat, Jaya Authunuri, Kavita Oberoi, Jo Crossan, Sharon Jones
Abstract
Introduction
Heart failure with reduced ejection fraction (HFrEF) affects 3.5–7.0% of patients aged 65–75 years, and up to 11% of those >80 years. Heart failure with preserved ejection fraction (HFpEF) accounts for at least half of heart failure diagnoses. The current overall prevalence of HFpEF (also known as HF with normal ejection fraction – HFnEF) and HFrEF is estimated to be 4.9% and 3.3%, respectively. Prevalence is expected to rise with an ageing population. There are multiple interventions proven to prolong life in patients with HFrEF.1
General practitioners (GPs) in the UK are financially incentivised by the Quality Outcome
|
Full text
